Real-time enrollment status for this metastatic hormone-sensitive prostate cancer (mhspc) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 12:35 PM UTC
| NCT Number | NCT07140900 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) |
| Phase | PHASE1 |
| Target Enrollment | 60 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Amgen |
| Last Updated on CT.gov | July 2, 2026 (Jul 2, 2026) |
As of August 28, 2026: Clinical trial NCT07140900 is currently recruiting participants. This phase1 study for metastatic hormone-sensitive prostate cancer (mhspc) is actively seeking new participants at 8 locations across the United States. The study is sponsored by Amgen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07140900 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07140900 was last updated Jul 2, 2026 (July 2, 2026). HelloStudys verifies this status automatically.